OKYO Pharma Limited Ordinary Shares (OKYO)
Business numbers score is on the low side; price trend score is near the bottom of its range; smart-money score is above the middle.
OKYO scores higher than 36% of the 1,101 tickers we compare it with (Health Care).
As of 10 October 2026, OKYO Pharma Limited Ordinary Shares (OKYO) scores 32 out of 100 on the Market Census six-factor composite, which puts it at the Below average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 10 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 1.51× 30-day average
- 52-week range
- 1.26 – 3.20
- Market cap
- —
- Earnings date
- —
- Volume
- 115,549
- Avg. volume (30d)
- 76,294
- Open
- 1.40
- Previous close
- 1.39
- Day's range (regular session)
- 1.35 – 1.53
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
Premium data held for OKYO
- 7 SEC Form 4 insider transactions in the last 90 daysPremium
Counts of rows Market Census holds for OKYO. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans
What the score says about OKYO right now
OKYO Pharma Limited Ordinary Shares (OKYO) currently scores 32/100 on the Market Census six-factor composite, at the Below average score level. OKYO is +2.16% on the day and -3.40% over five sessions as of the most recent tick. Below average sits a bit below the middle. More of OKYO's data reads poorly than well. The level is a "look before you act" flag. It is not advice. OKYO's strongest factor is insider trades at 90/100 — a very strong read on insider buying and selling. Insider filings currently lean toward buying on this name — a plain read of public filings, not a signal to follow. The weakest factor is company finances at 0/100 — well below average company numbers. A low company-finances reading is the canonical "value trap" warning: technical setups on broken fundamentals don't tend to compound.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See OKYO in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent OKYO news
Latest headlines that name OKYO Pharma, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- OKYO Pharma Begins Phase 3 NEPTUNE Trial of Urcosimod for Neuropathic Corneal PainYahoo
- OKYO Pharma enrolls first patients in Phase 3 trial of neuropathic corneal pain drugYahoo
- OKYO Pharma Announces First Patients Enrolled In Phase 3 NEPTUNE Trial Of Urcosimod For Neuropathic Corneal PainBenzinga
- OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific ConferencesYahoo
- OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026Yahoo
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to OKYO’s 32, all within 1 point.
Sorted by closeness to OKYO’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.